Chronic hyperhomocysteinemia induces oxidative damage in the rat lung

Molecular and Cellular Biochemistry

Volumn 358, Issue 1-2, 2011, Pages 153-160

  Da Cunha, Aline A ^a   Ferreira, Andréa G K ^a   Da Cunha, Maira J ^a   Pederzolli, Carolina D ^a   Becker, Débora L ^a   Coelho, Juliana G ^a   Dutra Filho, Carlos S ^a   Wyse, Angela T S ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Homocysteine; Lung; Nitrite levels; Oxidative stress

Indexed keywords

2',7'-DICHLOROFLUORESCEIN; CATALASE; DICHLOROFLUORESCEIN; FLUORESCEIN DERIVATIVE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; NITRITE; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CHRONIC DISEASE; DRUG EFFECT; ENZYMOLOGY; FLUORESCENCE; HYPERHOMOCYSTEINEMIA; LUNG; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; RAT; WISTAR RAT;

ANIMALS; CATALASE; CHRONIC DISEASE; FLUORESCEINS; FLUORESCENCE; GLUTATHIONE; GLUTATHIONE PEROXIDASE; HOMOCYSTEINE; HYPERHOMOCYSTEINEMIA; LUNG; MODELS, BIOLOGICAL; NITRITES; OXIDATIVE STRESS; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 84857169798     PISSN: 03008177     EISSN: 15734919     Source Type: Journal    
DOI: 10.1007/s11010-011-0930-2     Document Type: Article

References (70)

1. Diaz-Arrastia R (2000) Homocysteine and neurologic disease. Arch Neurol 57:1422-1427
2. Andersson A, Ankerst J, Lindgren A, Larsson K, Hultberg B (2001) Hyperhomocysteinemia and changed plasma thiol redox status in chronic obstructive puμmonary disease. Clin Chem Lab Med 39:229-233
3. Mattson MP, Kruman II, Duan W (2002) Folic acid and homocysteine in age-related disease. Ageing Res Rev 1:95-111
4. Bottiglieri T (2005) Homocysteine and folate metabolism in depression. Prog Neuropsychopharmacol Biol Psychiatry 29: 1103-1112
5. Obeid R, McCaddon A, Herrmann W (2007) The role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric diseases. Clin Chem Lab Med 45:1590-1606
6. Herrmann W, Lorenzl S, Obeid R (2007) Review of the role of hyperhomocysteinemia and B-vitamin deficiency in neurological and psychiatric disorders-current evidence and preliminary recommendations. Fortschr Neurol Psychiatr 75:515-527
7. Mudd SH, Levy HL, Skovby F (2001) Disorders of transsulfuration. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease, 8th edn. McGraw-Hill, New York, pp 1279-1327
8. Klastin G, Conn HO (1993) Hepatic lesions in disorders of protein and amino acid metabolism. Oxford University Press, New York
9. van der Berg M, van der Knapp MS, Boers GH, Stehouwer CD, Rauwerda JA, Valk J (1995) Hyperhomocysteinemia; with reference to its neuroradiological aspects. Neuroradiology 37:403-411
10. Welch GN, Loscalzo J (1998) Homocysteine and atherothrombosis. N Engl J Med 338:1042-1050
11. Kim WK, Pae YS (1996) Involvement of N-methyl-D-aspartate receptor and free radical in homocysteine-mediated toxicity on rat cerebellar granule cells in culture. Neurosci Lett 216:117-120
12. Zhang F, Slungaard A, Vercellotti GM, Ladecola C (1998) Superoxide-dependent cerebrovascular effects of homocysteine. Am J Physiol 274:R1704-R1711
13. Ho PI, Ashline D, Dhitavat S, Ortiz D, Collins SC, Shea TB, Rogers E (2003) Folate deprivation induces neurodegeneration: roles of oxidative stress and increased homocysteine. Neurobiol Dis 14:32-42
14. Jara-Prado A, Ortega-Vazquez A, Martinez-Ruano L, Rios C, Santamaria A (2003) Homocysteine-induced brain lipid peroxidation: effects ofNMDA receptor blockade, antioxidant treatment, and nitric oxide synthase inhibition. Neurotox Res 5:237-243
15. Dayal S, Arning E, Bottiglieri T, Boger RH, Sigmund CD, Faraci FM, Lentz SR (2004) Cerebral vascular dysfunction mediated by superoxide in hyperhomocysteinemic mice. Stroke 35:1957-1962
16. Faraci FM, Lentz SR (2004) Hyperhomocysteinemia, oxidative stress, and cerebral vascular dysfunction. Stroke 35:345-347
17. Tyagi N, Sedoris KC, Steed M, Ovechkin AV, Moshal KS, Tyagi SC (2005) Mechanisms of homocysteine-induced oxidative stress. Am J Physiol Heart Circ Physiol 289:H2649-H2656
18. Halliwell B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97:1634-1658
19. Zhu X, Smith MA, Honda K, Aliev G, Moreira PI, Nunomura A, Casadesus G, Harris PL, Siedlak SL, Perry G (2007) Vascular oxidative stress in Alzheimer disease. J Neurol Sci 257:240-246
20. Shi H, Liu KJ (2007) Cerebral tissue oxygenation and oxidative brain injury during ischemia and reperfusion. Front Biosci 12:1318-1328
21. Muhl D (2008) Changes in oxidative stress and hemostatic parameters in the course of thrombolytic therapy of puμmonary embolism. Orv Hetil 149:935-948
22. Halliwell B (2001) Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment. Drugs Aging 18:685-716
23. Halliwell B, Whiteman M (2004) Measuring reactive species and oxidative damage in vivo and in cell culture: how should you do it and what do the results mean? Br J Pharmacol 142:231-255
24. Halliwell B, Gutteridge JMC (2007) Free radicals in biology and medicine, 4th edn. Oxford University Press, New York, pp 79-185
25. Wyse AT, Zugno AI, Streck EL, Matté C, Calcagnotto T, Wannmacher CM, Wajner M (2002) Inhibition of Na+, K+-ATPase activity in hippocampus of rats subjected to acute administration of homocysteine is prevented by vitamins E and C treatment. Neurochem Res 27:1685-1689
26. Streck EL, Vieira PS, Wannmacher CM, Dutra-Filho C, Wajner M, Wyse AT (2003) In vitro effect of homocysteine on some parameters of oxidative stress in rat hippocampus. Metab Brain Dis 18:147-154
27. Matté C, Monteiro SC, Calcagnotto T, Bavaresco CS, Netto CA, Wyse AT (2004) In vivo and in vitro effects of homocysteine on Na+, K+-ATPase activity in parietal, prefrontal and cingulate cortex of young rats. Int J Dev Neurosci 22:185-190
28. Matté C, Scherer EB, Stefanello FM, Barschak AG, Vargas CR, Netto CA, Wyse AT (2007) Concurrent folate treatment prevents Na+, K+-ATPase activity inhibition and memory impairments caused by chronic hyperhomocysteinemia during rat development. Int J Dev Neurosci 25:545-552
29. Matté C, Stefanello FM, Mackedanz V, Pederzolli CD, Lamers ML, Dutra-Filho CS, dos Santos MF, Wyse AT (2009) Homocysteine induces oxidative stress, inflammatory infiltration, fibrosis and reduces glycogen/glycoprotein content in liver of rats. Int J Dev Neurosci 27:337-344
30. Streck EL, Matté C, Vieira PS, Rombaldi F, Wannmacher CM, Wajner M, Wyse AT (2002) Reduction of Na+, K+-ATPase activity in hippocampus of rats subjected to chemically induced hyperhomocysteinemia. Neurochem Res 27:1593-1598
31. Llesuy SF, Milei J, Molina H, Boveris A, Milei S (1985) Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 40-epiadriamycin in mice. Tumori 71:241-249
32. Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351-358
33. Stadtman ER (1990) Metal ion-catalyzed oxidation of proteins: biochemical mechanism and biological consequences. Free Radic Biol Med 9:315-325
34. Stadtman ER, Levine RL (2003) Free-radical mediated oxidation of free amino acids and amino acid residues in proteins. Amino Acids 25:207-218
35. Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357-363
36. LeBel CP, Ali SF, McKee M, Bondy SC (1990) Organometalinduced increases in oxygen reactive species: the potential of 20,70-dichlorofluorescein diacetate as an index of neurotoxic damage. Toxicol Appl Pharmacol 104:17-24
37. Lissi E, Pascual C, Del Castillo MD (1992) Luminol luminescence induced by 2,20-azo-bis-(2-amidinopropane) thermolysis. Free Radic Res Commun 17:299-311
38. Evelson P, Travacio M, Repetto M, Escobar J, Llesuy S, Lissi EA (2001) Evaluation of total reactive antioxidant potential (TRAP) of tissue homogenates and their cytosols. Arch Biochem Biophys 388:261-266
39. Marklund SL (1985) Pyrogallol autoxidation. In: Greenwald RA (ed) Handbook of methods for oxygen radical research. CRC Press, Boca Raton, pp 243-247
40. Aebi H (1984) Catalase, in vitro. Methods Enzymol 105:121-126
41. Wendel A (1981) Glutathione peroxidase. Methods Enzymol 77:325-333
42. Browne RW, Armstrong D (1998) Reduced glutathione and glutathione disulfide. Methods Mol Biol 108:347-352
43. Leong SF, Clark JB (1984) Regional enzyme development in rat brain. Enzymes associated with glucose utilization. Biochem J 218:131-138
44. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR (1982) Analysis of nitrate, nitrite and [15N]nitrate in biological fluids. Anal Biochem 126:131-138
45. Lowry OH, Rosebrough NJ, Farr AL, Randal RJ (1951) Protein measurement with the folin phenol reagent. J Biol Chem 193:265-275
46. Clarke R, Daly L, Robinson K (1999) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149-1155
47. Mattson MP, Haberman F (2003) Folate and homocysteine metabolism: therapeutic targets in cardiovascular and neurodegenerative disorders. Curr Med Chem 10:1923-1929
48. Jiang H, Wang XF, Fang L, Tang C, Zhu Y, Wang X (2005) Upregulation of aldose reductase by homocysteine in type II alveolar epithelial cells. Biochem Biophys Res Commun 337:1084-1091
49. Hamelet J, Maurin N, Fulchiron R, Delabar JM, Janel N (2007) Mice lacking cystathionine beta synthase have lung fibrosis and air space enlargement. Exp Mol Pathol 83:249-253
50. Dikshit M, Srivastava R, Srimal RC (1989) Role of free radicals in puμmonary thromboembolism in mice. Thromb Res 55:549-557
51. Ryrfeldt A, Bannenberg G, Moldeus P (1993) Free radicals and lung disease. Br Med Bull 49:588-603
52. Jacobsen DW (1998) Homocysteine and vitamins in cardiovascular disease. Clin Chem 44:1833-1843
53. Loscalzo J (1996) The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98:5-7
54. Mansoor MA, Bergmark C, Svardal AM, Lonning PE, Ueland PM (1995) Redox status and protein binding of plasma homocyst(e)ine and other aminothiols in patients with early-onset peripheral vascular disease. Arterioscler Thromb Vasc Biol 15: 232-240
55. Matté C, Mackedanz V, Stefanello FM, Scherer EB, Andreazza AC, Zanotto C, Moro AM, Garcia SC, Gonçalves CA, Erdtmann B, Salvador M, Wyse AT (2009) Chronic hyperhomocysteinemia alters antioxidant defenses and increases DNA damage in brain and blood os rats: protective effect of folic acid. Neurochem Int 54:7-13
56. Grisham MB, McCord J (1986) Chemistry and cytotoxicity of reactive oxygen metabolites. In: Taylor AE, Matalon S, Ward P (eds) Physiology of oxygen radicals. Williams and Wilkins Co, Baltimore, pp 1-18
57. Alvarez-Maqueda M, El Bekay R, Monteseirín J, Alba G, Chacón P, Vega A, Santa María C, Tejedo JR, Martín-Nieto J, Bedoya FJ, Pintado E, Sobrino F (2004) Homocysteine enhances superoxide anion release and NADPH oxidase assembly by human neutrophils. Effects on MAPK activation and neutrophil migration. Atherosclerosis 172:229-238
58. Fridorich I (1986) Biological effects of the superoxide radical. Arch Biochem Biophys 247:1-11
59. Blum J, Fridorich I (1985) Inactivation of glutathione peroxidase by superoxide radical. Arch Biochem Biophys 240:500-508
60. Vessey DA, Lee KH (1993) Inactivation of enzymes of the glutathione antioxidant system by treatment of culture human keratinocytes with peroxides. J Invest Dermatol 100:829-833
61. Heinecke JW, Rosen H, SuzukiI LA, Chait A (1987) The role of sulfur-containing amino acids in superoxide production and modification of low density lipoprotein in arterial smooth muscle cells. J Biol Chem 21:10098-10103
62. Upchurch GR Jr, Welch GN, Fabian AJ, Freedman JE, Johnson JL, Keaney JF Jr, Loscalzo J (1997) Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem 272:17012-17017
63. Stern F, Berner YN, Polyak Z, Komarnitsky M, Sela BA, Hopp M, Dror Y (2004) Homocysteine effect on protein degradation rates. Clin Biochem 37:1002-1009
64. Sharma P, Senthilkumar RD, Brahmachari V, Sundaramoorthy E, Mahajan A, Sharma A, Sengupta S (2006) Mining literature for a comprehensive pathway analysis: a case study for retrieval of homocysteine related genes for genetic and epigenetic studies. Lipids Health Dis 5:1-19
65. Kletzien RF, Harris PK, Foelμmi LA (1994) Glucose-6-phosphate dehydrogenase: a "housekeeping" enzyme subject to tissue-specific regulation by hormones, nutrients, and oxidant stress. FASEB J 8:174-181
66. Hashida K, Sakakura Y, Makino N (2002) Kinetic studies on the hydrogen peroxide elimination by cultured PC12 cells: rate limitation by glucose-6-phosphate dehydrogenase. Biochim Biophys Acta 1572:85-90
67. Rakhit RD, Mojet MH, Marber MS, Duchen MR (2001) Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes. Circulation 103:2617-2623
68. Beckman JS, Beckman TW, Chen J, Marshall PA, Freeman BA (1990) Apparent hydroxyl radical production by peroxinitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 87:1620-1624
69. Beckman JS, Koppenol WH (1996) Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 271:C1424-C1437
70. Eiserich JP, van der Vliet A, Handeμman GJ, Halliwell B, Cross CE (1995) Dietary antioxidants and cigarette smoke-induced biomolecular damage: a complex interaction. Am J Clin Nutr 62:S1490-S1500